Machine Learning Approaches Using High-Throughput Profiling Data for Antibiotic Discovery.

Area of Science:

• Microbiology
• Computational Biology
• Drug Discovery

Background:

• Rising global antibiotic resistance necessitates novel antibacterial agents.
• Identifying new compounds with unique mechanisms of action is challenging.
• Early-stage antibiotic discovery faces hurdles in pathway identification and mechanistic determination.

Purpose of the Study:

• To review advancements in high-throughput profiling for antibacterial discovery.
• To describe the application of machine learning (ML) in analyzing complex biological data.
• To highlight how ML and profiling accelerate the identification of novel antibacterial mechanisms.

Main Methods:

• Utilizing multilayered profiling: morphological phenotyping, transposon sequencing, transcriptomics, proteomics, and metabolomics.
• Integrating machine learning (ML) to analyze high-dimensional profiling data.
• Extracting complex patterns and predicting mechanisms of action for unknown compounds.

Main Results:

• ML effectively analyzes complex patterns in multilayered profiling data.
• Systematic approaches using ML overcome barriers in identifying novel antibacterial pathways.
• Profiling data captures cellular responses reflecting mechanisms of action.

Conclusions:

• ML integrated with high-throughput profiling systematically accelerates antibacterial discovery.
• These integrated approaches enable mechanistic validation and prioritization of lead compounds.
• Novel ML-driven strategies are crucial for developing new antibiotics with new mechanisms.